{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:11:10Z","timestamp":1790698270219,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1560,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bbmt.2010.06.021","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T05:29:49Z","timestamp":1279258189000},"page":"141-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy"],"prefix":"10.1016","volume":"17","author":[{"given":"William A.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sharf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Irons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamakshi","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Serody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Coghill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.06.021_bib1","first-page":"5","article-title":"CIBMTR summary slides part\u00a01","volume":"12","author":"Pasquini","year":"2006","journal-title":"CIBMTR Newslett"},{"key":"10.1016\/j.bbmt.2010.06.021_bib2","series-title":"Thomas\u2019 Hematopoietic Cell Transplantation","article-title":"Mobilization of autologous peripheral blood hematopoietic cells for cellular therapy","author":"Shea","year":"2009"},{"key":"10.1016\/j.bbmt.2010.06.021_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/bmt.2008.410","article-title":"Improving stem cell mobilization strategies: future directions","volume":"43","author":"Bensinger","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.021_bib4","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1200\/JCO.1995.13.10.2547","article-title":"Factors that influence collection and engraftment of autologous peripheral blood stem cells","volume":"13","author":"Bensinger","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.06.021_bib5","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/leu.2009.127","article-title":"International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)","volume":"23","author":"Giralt","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.06.021_bib6","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood-2009-04-205013","article-title":"Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens","volume":"114","author":"Kumar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.021_bib7","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma","volume":"113","author":"DiPersio","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.021_bib8","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/sj.leu.2405035","article-title":"Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients","volume":"22","author":"Mazumder","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.06.021_bib9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bbmt.2009.02.011","article-title":"Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma","volume":"15","author":"Popat","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.021_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bmt.1700867","article-title":"Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone","volume":"20","author":"Alegre","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.021_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbmt.2004.02.001","article-title":"Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage-colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma","volume":"10","author":"Arora","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.021_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/14653240701452800","article-title":"Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma","volume":"9","author":"Hiwase","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2010.06.021_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bbmt.2008.04.008","article-title":"Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma","volume":"14","author":"Mark","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.021_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/bmt.2008.369","article-title":"Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma","volume":"43","author":"Gertz","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.021_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.bmt.1702879","article-title":"A comparison of toxicity following 2 different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients","volume":"27","author":"Fitoussi","year":"2001","journal-title":"Bone Marrow Transplantat"},{"key":"10.1016\/j.bbmt.2010.06.021_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1537-2995.2007.01164.x","article-title":"Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells","volume":"47","author":"Hicks","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2010.06.021_bib17","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1200\/JCO.1992.10.12.1955","article-title":"Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients","volume":"10","author":"Gianni","year":"1992","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.06.021_bib18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1046\/j.1537-2995.1997.37111298088057.x","article-title":"Circulating CD34+ cell counts are predictive of CD34+ peripheral blood progenitor cell yields","volume":"37","author":"Bandarenko","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2010.06.021_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s002770050598","article-title":"Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myeloma","volume":"78","author":"Kobbe","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2010.06.021_bib20","first-page":"621","article-title":"Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study","volume":"91","author":"De la Rubia","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2010.06.021_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s002770100351","article-title":"Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma","volume":"80","author":"Perea","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2010.06.021_bib22","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/sj.leu.2404801","article-title":"Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma","volume":"21","author":"Kumar","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.06.021_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1200\/JCO.1997.15.2.759","article-title":"Mobilization of peripheral blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin\u2019s lymphoma, and Hodgkin\u2019s disease","volume":"15","author":"Copelan","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.bbmt.2010.06.021_bib24","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood.V95.5.1588.005k38_1588_1593","article-title":"Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors","volume":"95","author":"Krishnan","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.06.021_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.bmt.1704532","article-title":"Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation","volume":"34","author":"Copelan","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.06.021_bib26","series-title":"Thomas\u2019 Hematopoietic Cell Transplantation","article-title":"Hematopoietic cell transplantation for multiple myeloma","author":"Qazilbash","year":"2009"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110002946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110002946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:37:09Z","timestamp":1761057429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879110002946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1083879110002946"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.06.021","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}